Company intelligence / Profile preview

AMF Medical

St-Sulpice, Switzerland

Ownership: Public · TNDM
Development stage: Other

Overview

AMF Medical developed the Sigi Patch Pump, a next-generation interoperable, semi-reusable, rechargeable patch insulin pump using standard pre-filled insulin cartridges. The device received FDA Breakthrough Device Designation in November 2021 but was not yet FDA-cleared or CE-marked at the time of acquisition.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Tandem Diabetes Care (acquirer)

Beyond the preview

Go deeper on AMF Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMF Medical.

Explore the full profile